Cardiovascular Interventions Related Topics 
DAIC
MAY 31, 2024
This transaction further extends Johnson & Johnson MedTech’s leadership in cardiovascular intervention. We are excited to begin collaborating directly with the Shockwave team and look forward to a bright future together.”
DAIC
APRIL 5, 2024
The acquisition of Shockwave further extends Johnson & Johnson MedTech’s position in cardiovascular intervention and accelerates its shift into higher-growth markets. Cardiovascular intervention is one of the fastest-growing global medtech markets, with significant unmet patient need.
DAIC
APRIL 12, 2024
Getty Images milla1cf Fri, 04/12/2024 - 20:55 April 12, 2024 — Simpson Interventions, Inc. , Food and Drug Administration ( FDA ).
Cardiology Update
MAY 27, 2024
EuroPCR is the annual official congress of the European Association of Percutaneous Cardiovascular Interventions (EACPI). EuroPCR 2024 was held 14-17 May in Paris, France. In this episode Dr. Chadi Alraies discusses the top 10 sessions from EuroPCR 2024.
Journal of Cardiovascular Pharmacology
MARCH 13, 2024
No abstract available
American College of Cardiology
DECEMBER 10, 2024
A State-of-the-Art review published in JACC: Cardiovascular Interventions covers the epidemiology, clinical implications, risk factors and preventive strategies for new-onset conduction disturbances (CDs) and the need for permanent pacemaker implantation (PPI) after TAVR, which the authors note are a limitation of this therapy.
European Journal of Heart Failure
DECEMBER 22, 2023
While medical therapy for right-sided heart failure is limited, treatment options for tricuspid regurgitation include surgery and, based on recent developments, several transcatheter interventions.
Expert insights. Personalized for you.
104 
Let's personalize your content